| CLASS | ABXBACT | LP7755-4 |
| COMPONENT | Extended-spectrum beta lactamase by ceftazidime to ceftazidime+clavulanate inhibitory concentration ratio | LP232452-5 |
| PROPERTY | Imp | LP6819-9 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Bld.pos growth | LP183539-8 |
| SCALE_TYP | Ord | LP7751-3 |
| METHOD_TYP | Based on lab data | LP426925-6 |
| AnswerList | Detected|Not det | LL744-4 |
| parent | ESBL by ceftazidime to ceftazidime-clavulanate IC ratio | Positive blood culture | Antibiotic susceptibilities | LP434932-2 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| UNITSREQUIRED | N | |
| STATUS | ACTIVE |
| LONG_COMMON_NAME | en-US | ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative |
| LONG_COMMON_NAME | en-US | ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative |
| SHORTNAME | en-US | ESBL cft to cft-clav IC rto Bd Pos Imp |
| ConsumerName | en-US | ESBL by ceftazidime to ceftazidime-clavulanate IC Ratio, Infected blood |
| LONG_COMMON_NAME | fr-FR | Ratio CMI bêta lactamase à spectre élargi ceftazidime/ceftazidime+clavulanate [Interprétation] Hémoculture positive ; Qualitatif ; Basé sur les données de laboratoire |
LOINC Version: 2.81
FHIR